These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2788783)

  • 1. Sensitivity of fresh leukemic cells to T101 ricin A-chain immunotoxin: a comparative study between Fab fragment and whole Ig conjugates.
    Chiron M; Derocq JM; Kuhlein E; Roubinet F; Demur C; Grandjean H; Huguet F; Jaffrezou JP; Jansen F; Laurent G
    Leuk Res; 1989; 13(6):491-9. PubMed ID: 2788783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the cytotoxic potency of T101 Fab, F(ab')2 and whole IgG immunotoxins.
    Derocq JM; Casellas P; Laurent G; Ravel S; Vidal H; Jansen F
    J Immunol; 1988 Oct; 141(8):2837-43. PubMed ID: 3262669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-lymphocyte killing by T101-ricin A-chain immunotoxin: pH-dependent potentiation with lysosomotropic amines.
    Casellas P; Ravel S; Bourrié BJ; Derocq JM; Jansen FK; Laurent G; Gros P
    Blood; 1988 Oct; 72(4):1197-202. PubMed ID: 3262384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An anti-CD5 immunotoxin for chronic lymphocytic leukemia: enhancement of cytotoxicity with human serum albumin-monensin.
    Hertler AA; Schlossman DM; Borowitz MJ; Blythman HE; Casellas P; Frankel AE
    Int J Cancer; 1989 Feb; 43(2):215-9. PubMed ID: 2465276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of ricin A chain immunotoxin activity by perhexiline on established and fresh leukemic cells.
    Jaffrézou JP; Levade T; Kuhlein E; Thurneyssen O; Chiron M; Grandjean H; Carrière D; Laurent G
    Cancer Res; 1990 Sep; 50(17):5558-66. PubMed ID: 2386962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I study of T101-ricin A chain immunotoxin in refractory chronic lymphocytic leukemia.
    Hertler AA; Schlossman DM; Borowitz MJ; Laurent G; Jansen FK; Schmidt C; Frankel AE
    J Biol Response Mod; 1988 Feb; 7(1):97-113. PubMed ID: 3373237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Internalization of the cytotoxic molecules of T101 F(ab')2-(ricin-A-chain) immunotoxin into human T-leukemic cells.
    Ravel S; Casellas P
    Eur J Biochem; 1990 Sep; 192(2):469-73. PubMed ID: 2209602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human T-cell tumor growth by T101-ricin A-chain in an athymic mouse model.
    Leonard JE; Johnson DE; Shawler DL; Dillman RO
    Cancer Res; 1988 Sep; 48(17):4862-7. PubMed ID: 3261627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo enhancement of ricin-A chain immunotoxin activity by novel indolizine calcium channel blockers: delayed intracellular degradation linked to lipidosis induction.
    Jaffrézou JP; Levade T; Thurneyssen O; Chiron M; Bordier C; Attal M; Chatelain P; Laurent G
    Cancer Res; 1992 Mar; 52(5):1352-9. PubMed ID: 1737397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor bone marrow treatment with T101 Fab fragment-ricin A-chain immunotoxin prevents graft-versus-host disease.
    Laurent G; Maraninchi D; Gluckman E; Vernant JP; Derocq JM; Gaspard MH; Rio B; Michalet M; Reiffers J; Dreyfus F
    Bone Marrow Transplant; 1989 Jul; 4(4):367-71. PubMed ID: 2789084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin A and cyclosporin SDZ PSC 833 enhance anti-CD5 ricin A-chain immunotoxins in human leukemic T cells.
    Jaffrézou JP; Sikic BI; Laurent G
    Blood; 1994 Jan; 83(2):482-9. PubMed ID: 7506953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability and cytotoxicity of Fab-ricin A immunotoxins prepared with water soluble long chain heterobifunctional crosslinking agents.
    Woo BH; Lee JT; Park MO; Lee KR; Han JW; Park ES; Yoo SD; Lee KC
    Arch Pharm Res; 1999 Oct; 22(5):459-63. PubMed ID: 10549572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of protein synthesis inactivation in human T-lymphocytes by selective monoclonal antibody-ricin conjugates.
    Leonard JE; Wang QC; Kaplan NO; Royston I
    Cancer Res; 1985 Nov; 45(11 Pt 1):5263-9. PubMed ID: 3876881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic effect of anti-Mr 67,000 protein immunotoxins on human tumors in a nude mouse model.
    Weil-Hillman G; Runge W; Jansen FK; Vallera DA
    Cancer Res; 1985 Mar; 45(3):1328-36. PubMed ID: 3971376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific ex-vivo depletion of human bone marrow T lymphocytes by an anti-pan-T cell (CD5) ricin A-chain immunotoxin.
    Siena S; Villa S; Bonadonna G; Bregni M; Gianni AM
    Transplantation; 1987 Mar; 43(3):421-6. PubMed ID: 3103275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amantadine potentiates T lymphocyte killing by an anti-pan-T cell (CD5) ricin A-chain immunotoxin.
    Siena S; Villa S; Bregni M; Bonnadonna G; Gianni AM
    Blood; 1987 Jan; 69(1):345-8. PubMed ID: 3098324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ricin A immunotoxins of IgG and Fab of anti-CALLA monoclonal antibody: effect of water soluble long-chain SPDP on conjugate yield, immunoselectivity and cytotoxicity.
    Woo BH; Lee JT; Lee KC
    Arch Pharm Res; 1994 Dec; 17(6):452-7. PubMed ID: 10319157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of four CD22 antibodies as ricin A chain-containing immunotoxins for the in vivo therapy of human B-cell leukemias and lymphomas.
    Shen GL; Li JL; Ghetie MA; Ghetie V; May RD; Till M; Brown AN; Relf M; Knowles P; Uhr JW
    Int J Cancer; 1988 Nov; 42(5):792-7. PubMed ID: 3263328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of antibody valency and lysosomotropic amines on the synergy between ricin A chain- and ricin B chain-containing immunotoxins.
    Fulton RJ; Uhr JW; Vitetta ES
    J Immunol; 1986 Apr; 136(8):3103-9. PubMed ID: 3958490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Internalization and intracellular fate of anti-CD5 monoclonal antibody and anti-CD5 ricin A-chain immunotoxin in human leukemic T cells.
    Ravel S; Colombatti M; Casellas P
    Blood; 1992 Mar; 79(6):1511-7. PubMed ID: 1372189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.